Impact of protein-glycan interactions in the regulation of autoimmunity and chronic inflammation

Autoimmunity Reviews

Volumn 5, Issue 5, 2006, Pages 349-356

  Bianco, Germán A ^a   Toscano, Marta A ^a   Ilarregui, Juan M ^a   Rabinovich, Gabriel A ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Apoptosis; Autoimmunity; Galectin 1; Galectins; Glycosylation; Immunoregulation

Indexed keywords

AMINO ACID; ANTIINFLAMMATORY AGENT; ANTISENSE OLIGONUCLEOTIDE; CARBOHYDRATE BINDING PROTEIN; COLLAGEN; CONCANAVALIN A; CYTOKINE; ECALECTIN; ELECTROLECTIN; GALACTOSE; GALECTIN; GALECTIN 1; GALECTIN 10; GALECTIN 11; GALECTIN 13; GALECTIN 14; GALECTIN 15; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTIN 5; GALECTIN 7; GLYCAN; IMMUNOSUPPRESSIVE AGENT; LECTIN; OLIGOSACCHARIDE; RECOMBINANT GALECTIN; RECOMBINANT GALECTIN 1; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; APOPTOSIS; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BINDING AFFINITY; CANCER; CANCER IMMUNOLOGY; CELL BASED GENE THERAPY; CELL SURVIVAL; CHEMOPROPHYLAXIS; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG MECHANISM; DRUG TARGETING; ENTERITIS; EXPERIMENTAL MODEL; GENE TARGETING; GENE THERAPY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE COMPLEX NEPHRITIS; IMMUNE MEDIATED INJURY; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFLAMMATORY DISEASE; KIDNEY DISEASE; LIVER INJURY; LIVER PROTECTION; LYMPHOCYTE DIFFERENTIATION; MELANOMA; MOLECULAR BIOLOGY; MYASTHENIA GRAVIS; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TOXIC HEPATITIS; UVEITIS;

ANIMALS; AUTOIMMUNITY; GALECTINS; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; PROTEINS;

EID: 33744999160     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.02.003     Document Type: Review

References (40)

1. Lowe J.B. Glycosylation, immunity, and autoimmunity. Cell 104 (2001) 809-812
2. Sharon N., and Lis H. History of lectins: from hemagglutinins to biological recognition molecules. Glycobiology 14 (2004) 53R-62R
3. Gabius H.J. Animal lectins. Biochem Biophys Acta 1572 (2002) 163-434
4. Liu F.T., and Rabinovich G.A. Galectins as modulators of tumour progression. Nat Rev Cancer 5 (2005) 29-41
5. Rabinovich G.A., Baum L.G., Tinari N., Paganelli R., Natoli C., Liu F.T., et al. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response. Trends Immunol 23 (2002) 313-320
6. Levi G., Tarrab-Hazadai R., and Teichberg V.I. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur J Immunol 13 (1983) 500-507
7. Offner H., Celnik B., Bringman T.S., Casentini-Borocz D., Nedwin G.E., and Vandenbark A.A. Recombinant human beta-galactoside binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J Neuroimmunol 28 (1990) 177-184
8. Zhu C., Anderson A.C., Schubart A., Xiong H., Imitola J., Khoury S.J., et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6 (2005) 1245-1252
9. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., et al. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190 (1999) 385-397
10. Harjack M., Diaz-Cano S., de Miguel M., Wolfe H., Maldonado C.A., and Rabinovich G.A. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis. J Rheumatol 28 (2001) 1914-1922
11. Ohshima S., Kuchen S., Seemayer C.A., Kyburz D., Hirt A., Klinzing S., et al. Galectin-3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 48 (2003) 2788-2795
12. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazetti B., Federici B., et al. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 124 (2003) 1381-1394
13. Santucci L., Fiorucci S., Cammilleri F., Servillo G., Federici B., and Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology 31 (2000) 399-406
14. +T cells with an epithelial cell lectin, galectin-4, contributes to exacerbation of intestinal inflammation. Immunity 20 (2004) 681-693
15. Tsuchiyama Y., Wada J., Zhang H., Morita Y., Hiragushi K., Hida K., et al. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int 58 (2000) 1941-1952
16. Toscano MA, Commodaro AG, Ilarregui JM, Bianco GA, Liberman A, Serra HM, et al., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant T helper (Th)2- and T regulatory mediated anti-inflammatory responses. J Immunol in press.
17. Romero M.D., Muiño J.C., Bianco G.A., Ferrero M., Juarez C.P., Luna J.D., et al. Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis. Invest Ophthalmol Vis Sci 47 (2006) 1550-1556
18. Baum L.G., Blackall D.P., Arias-Magallano S., Nanigian D., Uh S.Y., Browne J.M., et al. Amelioration of graft versus host disease by galectin-1. Clin Immunol 109 (2003) 295-307
19. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo I., et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell 5 (2004) 241-251
20. Le Q.T., Shi G., Cao H., Nelson D.W., Wang Y., Chen E.Y., et al. Galectin-1: a link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 (2005) 8932-8941
21. Blaser C., Kaufmann M., Muller C., Zimmermann C., Wells V., Malluci L., et al. β-Galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 28 (1998) 2311-2319
22. Perillo N.L., Pace K.E., Seilhamer J.J., and Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 378 (1995) 736-739
23. Matarrese P., Tinari A., Mormone E., Bianco G.A., Toscano M.A., Ascione B., et al. Galectin-1 sensitizes resting human T lymphocytes to Fas (CD95)-mediated cell death via mitrochondrial hyperpolarization, budding and fission. J Biol Chem 280 (2005) 6969-6985
24. Sturm A., Lensch M., Andre S., Kaltner H., Wiedenmann B., Rosewicz S., et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 173 (2004) 3825-3837
25. Yang R.Y., Hsu D.K., and Liu F.T. Expression of galectin-3 modulates T cell growth and apoptosis. Proc Natl Acad Sci USA 93 (1996) 6737-6742
26. Fukumori T., Takenaka Y., Yoshii T., Kim H.R., Hogan V., Inohara H., et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63 (2003) 8302-8311
27. Stillman B.N., Hsu D.K., Pang M., Brewer C.F., Johnson P., Liu F.T., et al. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176 (2006) 778-789
28. Fajka-Boja R., Szemes M., Ion G., Legradi A., Caron M., and Monostori E. Receptor tyrosine phosphatase, CD45 binds galectin-1 but does not mediate its apoptotic signal in T cell lines. Immunol Lett 82 (2002) 149-154
29. Galvan M., Tsuboi S., Fukuda M., and Baum L.G. Expression of a specific glycosyltransferase enzyme regulates T cell death mediated by galectin-1. J Biol Chem 275 (2000) 16730-16737
30. Amano M., Galvan M., He J., and Baum L.G. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation and T cell death. J Biol Chem 278 (2003) 7469-7475
31. Ion G., Fajka-Boja R., Toth G.K., Caron M., and Monostori E. Role of p56(lck) and ZAP70-mediated tyrosine phosphorylation in galectin-1-induced cell death. Cell Death Diff 12 (2005) 145-1147
32. Hahn H.P., Pang M., He J., Hernandez J.D., Yang R.Y., Li L.Y., et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase-and cytochrome c-independent T cell death. Cell Death Diff 11 (2004) 1277-1286
33. Kashio Y., Nakamura K., Abedin M.J., Seki M., Nishi N., Yoshida N., et al. Galectin-9 induces apoptosis through the calcium-calpain-caspase 1 pathway. J Immunol 170 (2003) 3631-3636
34. Vespa G.N., Lewis L.A., Kozak K.R., Moran M., Nguyen J.T., Baum L.G., et al. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibits IL-2 production and proliferation. J Immunol 162 (1999) 799-806
35. Chung C.D., Patel V.P., Moran M., Lewis L.A., and Miceli M.C. Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol 165 (2000) 3722-3729
36. Demetriou N., Granovsky M., Quaggin S., and Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
37. Rabinovich G.A., Ariel A., Hershkoviz R., Hirabayashi J., Kasai K.I., and Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and pro-inflammatory cytokine secretion by human recombinant galectin-1. Immunology 97 (1999) 100-106
38. van der Leij J., van den Berg A., Blokzijl T., Harms G., van Goor H., Zwiers P., et al. Dimeric galectin-1 induces IL-10 production in T-lymphocytes: an important tool in the regulation of the immune response. J Pathol 204 (2004) 511-518
39. Lopez E., Del Pozo V., Miguel T., Sastre B., Seoane C., Civantos E., et al. Inhibition of chronic airway inflammation and remodeling by galectin-3 gene therapy in a murine model. J Immunol 176 (2006) 1943-1950
40. Zuberi R.I., Hsu D.K., Kalayci O., Chen H.Y., Sheldon H.K., Yu L., et al. Critical role for galectin-3 in airway inflammation and bronchial hyperresponsiveness in a murine model of asthma. Am J Pathol 165 (2004) 2045-2053